Immune dysregulation in patients with severe acute pancreatitis.
To investigate patients with severe acute pancreatitis (SAP) by dynamic levels of pro-/anti-inflammatory cytokines and endotoxin (ET) in plasma and the relationship between immunity and infection, organ dysfunction. Seventy-two patients with SAP were recruited. The ET, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-10 (IL-10), and interleukin-4 (IL-4) were determined on admission and days 3, 7, and 14. For comparison, patients were analyzed through infection group versus non-infection group, multiple organ dysfunction syndrome (MODS) group versus non-MODS group. There were sixteen patients with secondary infection, twenty-two with MODS, and nine deaths. The infection group had higher levels of ET than the non-infection group on days 3 and 7. The dynamic cytokine levels of patients in the MODS group were unanimous with those outcomes in the infection group. The levels of cytokines in the infection group were different from the non-infection group, with more levels of TNF-α, IL-6 on days 3 and 7 and less on days 14, and more levels of IL-10, IL-4 on days 7 and 14. The levels of TNF-α, IL-6 in the MODS group were different from the non-MODS group, with more levels on days 3 and 7, and less levels on days 14. Immune dysregulation may play an important role in infection and organ dysfunction for patients with SAP.
Shen
YinFeng
Y
National Medical Center of Biliopancreatic Diseases, Nankai Hospital, Nankai Clinical School, Tianjin Medical University, Tianjin, People's Republic of China.
Cui
NaiQiang
N
Miao
Bing
B
Zhao
ErPeng
E
D000293:Adolescent; D000328:Adult; D000368:Aged; D016207:Cytokines / Q000097:blood*; D004731:Endotoxins / Q000097:blood*; D005260:Female; D006801:Humans; D007239:Infections / Q000150:complications*; D016753:Interleukin-10 / Q000097:blood; D015847:Interleukin-4 / Q000097:blood; D015850:Interleukin-6 / Q000097:blood; D008297:Male; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000209:etiology / Q000401:mortality; D010195:Pancreatitis / Q000150:complications* / Q000276:immunology* / Q000401:mortality; D018746:Systemic Inflammatory Response Syndrome / Q000276:immunology; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
D016207:Cytokines; D004731:Endotoxins; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10; D015847:Interleukin-4
World J Gastroenterol. 2007 Oct 14;13(38):5043-51
17876868
Crit Care Med. 2004 Dec;32(12):2457-63
15599151
Pancreas. 2009 Mar;38(2):122-5
18797421
Pancreas. 2004 Mar;28(2):211-3
15028955
J Gastroenterol. 2006 Aug;41(8):779-84
16988767
Pancreas. 2008 Apr;36(3):e10-5
18362832
Crit Care Med. 1992 Jun;20(6):864-74
1597042
Pancreas. 2005 Mar;30(2):e46-50
15714129
Pancreas. 2003 Jan;26(1):18-22
12499912
Cytokine. 2002 Jan 7;17(1):53-9
11886171
Am J Respir Cell Mol Biol. 2006 Aug;35(2):198-205
16574946
Ann Surg. 2006 Feb;243(2):154-68
16432347
Scand J Gastroenterol. 2006 Apr;41(4):472-80
16635917
Digestion. 2001;63(2):69-91
11244246
Pancreas. 2008 Mar;36(2):192-6
18376312
Pancreas. 2008 Aug;37(2):170-5
18665079
Pancreas. 2008 Oct;37(3):e74-82
18815542
Pancreas. 2009 Jul;38(5):499-502
19342981
Pancreas. 2008 Oct;37(3):295-301
18815552
Crit Care Med. 1996 Jan;24(1):163-72
8565523
Curr Opin Crit Care. 2007 Aug;13(4):416-20
17599012
J Hepatobiliary Pancreat Surg. 2002;9(4):401-10
12483260
J Zhejiang Univ Sci B. 2009 Jul;10(7):493-8
19585666
Chest. 2003 Sep;124(3):1103-15
12970043
Pancreatology. 2003;3(2):93-101
12774801
Ann Surg. 2000 Nov;232(5):619-26
11066131
Arch Surg. 1993 May;128(5):586-90
8489394
Pancreas. 2006 Aug;33(2):174-83
16868484
Hepatogastroenterology. 2005 Jul-Aug;52(64):990-4
16001614